Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 07 04:00PM ET
37.86
Dollar change
-0.05
Percentage change
-0.13
%
Index- P/E- EPS (ttm)-2.53 Insider Own8.32% Shs Outstand157.71M Perf Week-5.49%
Market Cap5.97B Forward P/E- EPS next Y-3.41 Insider Trans-0.33% Shs Float144.59M Perf Month-19.26%
Income-365.48M PEG- EPS next Q-1.12 Inst Own90.05% Short Float7.34% Perf Quarter-19.52%
Sales813.95M P/S7.34 EPS this Y-38.98% Inst Trans0.60% Short Ratio6.80 Perf Half Y-10.37%
Book/sh1.81 P/B20.97 EPS next Y4.14% ROA-12.91% Short Interest10.61M Perf Year-19.19%
Cash/sh13.18 P/C2.87 EPS next 5Y35.30% ROE-105.63% 52W Range35.95 - 54.44 Perf YTD-25.16%
Dividend Est.- P/FCF- EPS past 5Y- ROI-16.64% 52W High-30.46% Beta0.39
Dividend TTM- Quick Ratio7.51 Sales past 5Y13.97% Gross Margin95.83% 52W Low5.31% ATR (14)1.33
Dividend Ex-Date- Current Ratio7.61 EPS Y/Y TTM-16.73% Oper. Margin-44.83% RSI (14)28.85 Volatility2.84% 3.23%
Employees927 Debt/Eq7.50 Sales Y/Y TTM29.06% Profit Margin-44.90% Recom1.74 Target Price61.73
Option/ShortYes / Yes LT Debt/Eq7.33 EPS Q/Q23.83% Payout- Rel Volume1.00 Prev Close37.91
Sales Surprise44.15% EPS Surprise51.36% Sales Q/Q19.55% EarningsAug 01 BMO Avg Volume1.56M Price37.86
SMA20-8.39% SMA50-16.47% SMA200-16.10% Trades Volume1,557,018 Change-0.13%
Date Action Analyst Rating Change Price Target Change
Aug-02-24Downgrade BMO Capital Markets Outperform → Market Perform $67 → $60
Jul-24-24Upgrade Leerink Partners Market Perform → Outperform $53 → $62
Jul-16-24Resumed Jefferies Buy $29 → $75
Jun-14-24Upgrade Bernstein Underperform → Mkt Perform $44
Apr-10-24Upgrade Wolfe Research Peer Perform → Outperform $58
Jan-02-24Upgrade BofA Securities Neutral → Buy $52 → $62
Oct-23-23Upgrade BofA Securities Underperform → Neutral $33 → $52
Sep-29-23Initiated Raymond James Strong Buy $63
Jul-31-23Upgrade Citigroup Neutral → Buy $36 → $60
Jun-07-23Resumed Piper Sandler Overweight $58
Oct-03-24 07:00AM
Oct-01-24 06:59PM
07:00AM
Sep-12-24 01:01PM
Sep-09-24 09:10PM
04:20PM Loading…
04:20PM
Sep-04-24 08:00AM
07:30AM
Aug-28-24 07:05AM
Aug-15-24 09:15AM
Aug-13-24 07:00AM
Aug-06-24 11:34PM
Aug-02-24 01:32PM
09:54AM
04:34AM
10:00AM Loading…
Aug-01-24 10:00AM
08:20AM
07:32AM
07:00AM
Jul-31-24 09:00AM
Jul-25-24 10:02AM
Jul-23-24 09:53AM
07:03AM
Jul-22-24 04:27PM
08:14AM
07:00AM
Jul-19-24 09:56AM
08:24AM
06:32AM
Jul-18-24 07:00AM
08:00AM Loading…
Jul-17-24 08:00AM
Jul-08-24 07:05AM
Jun-26-24 12:56PM
Jun-25-24 06:55AM
06:30AM
Jun-19-24 12:11PM
Jun-18-24 07:00AM
Jun-17-24 04:09PM
Jun-06-24 11:31AM
May-31-24 12:25PM
07:00AM
May-28-24 07:00AM
May-23-24 07:00AM
May-17-24 10:10AM
May-16-24 12:46PM
10:54AM
08:50AM
08:05AM
07:51AM
07:37AM
07:30AM
07:30AM
07:00AM
May-15-24 07:05AM
May-13-24 07:00AM
May-09-24 06:30AM
May-08-24 03:15PM
10:59AM
10:39AM
05:20AM
03:40AM
May-07-24 05:02PM
04:43PM
09:30AM
08:10AM
08:07AM
07:07AM
07:00AM
May-06-24 09:15AM
Apr-30-24 10:00AM
Apr-25-24 07:00AM
Apr-23-24 07:05AM
Apr-07-24 09:48AM
Apr-01-24 07:05AM
Mar-28-24 07:05AM
Mar-25-24 09:09AM
08:18AM
Mar-22-24 11:30AM
Mar-21-24 03:00PM
Mar-17-24 08:50AM
Mar-14-24 10:40AM
Mar-13-24 07:17AM
07:07AM
07:00AM
Mar-06-24 07:30AM
Feb-29-24 09:05AM
Feb-28-24 07:05AM
Feb-22-24 12:12PM
10:59AM
10:29AM
02:20AM
Feb-21-24 11:31AM
09:30AM
08:05AM
07:06AM
07:00AM
Feb-15-24 09:15AM
07:00AM
Feb-14-24 10:00AM
Feb-09-24 10:44AM
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Geary Richard SEVP, Chief Development OfficerAug 29 '24Sale49.6333116,42884,823Sep 03 07:18 PM
Geary Richard SEVP, Chief Development OfficerAug 28 '24Sale49.1632015,73185,154Sep 03 07:18 PM
Geary Richard SEVP, Chief Development OfficerAug 05 '24Sale48.002,430116,64085,508Aug 06 05:27 PM
Geary Richard SExecutive Vice President, ChieAug 05 '24Proposed Sale49.133,128153,678Aug 05 04:11 PM
WENDER JOSEPH HDirectorJul 15 '24Option Exercise0.004,6770132,756Jul 17 05:03 PM
PARSHALL B LYNNEDirectorJul 15 '24Option Exercise0.004,677087,265Jul 17 05:03 PM
LOSCALZO JOSEPHDirectorJul 15 '24Option Exercise0.004,677045,759Jul 17 05:03 PM
KLEIN JOSEPH IIIDirectorJul 16 '24Option Exercise24.4212,000293,04012,000Jul 17 05:02 PM
KLEIN JOSEPH IIIDirectorJul 16 '24Sale50.0012,000600,0000Jul 17 05:02 PM
HERMAN JOAN EDirectorJul 15 '24Option Exercise0.004,677042,007Jul 17 05:02 PM
Diaz Allene M.DirectorJul 15 '24Option Exercise0.004,677017,353Jul 17 05:02 PM
Diaz Allene M.DirectorJul 16 '24Sale49.491,63781,01915,716Jul 17 05:02 PM
BERTHELSEN SPENCER RDirectorJul 15 '24Option Exercise0.004,6770151,934Jul 17 05:02 PM
BERTHELSEN SPENCER RDirectorJun 17 '24Option Exercise35.5316,000568,480163,257Jun 20 05:52 PM
BERTHELSEN SPENCER RDirectorJun 17 '24Sale40.2916,000644,640147,257Jun 20 05:52 PM
WENDER JOSEPH HDirectorMay 09 '24Option Exercise35.5316,000568,480128,079May 13 05:25 PM
KLEIN JOSEPH IIIDirectorMay 03 '24Sale42.716,000256,2770May 07 04:55 PM
Baroldi JosephEVP, Chief Business OfficerApr 15 '24Option Exercise0.0010,838023,637Apr 17 05:19 PM
Baroldi JosephEVP, Chief Business OfficerApr 16 '24Sale41.604,006166,64119,631Apr 17 05:19 PM
Birchler BrianEVP, Corp and Development OpsApr 15 '24Option Exercise0.001,875047,061Apr 17 05:16 PM
Birchler BrianEVP, Corp and Development OpsApr 16 '24Sale41.6690537,69846,156Apr 17 05:16 PM
Monia Brett PChief Executive OfficerFeb 16 '24Sale44.4938717,219173,751Feb 16 07:47 PM
Swayze EricEVP ResearchJan 31 '24Sale52.0010,773560,19632,516Feb 02 07:55 PM
Swayze EricEVP ResearchFeb 02 '24Sale49.561,90794,51334,324Feb 02 07:55 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrFeb 02 '24Sale49.592,071102,70149,812Feb 02 07:55 PM
O'NEIL PATRICK R.EVP CLO & General CounselFeb 02 '24Sale49.671,96197,41048,661Feb 02 07:55 PM
Monia Brett PChief Executive OfficerFeb 02 '24Sale49.3723,5011,160,303174,138Feb 02 07:55 PM
HOUGEN ELIZABETH LEVP, Finance & CFOFeb 02 '24Sale49.542,125105,27292,905Feb 02 07:55 PM
Geary Richard SEVP, Chief Development OfficerFeb 02 '24Sale50.041,96198,13587,334Feb 02 07:54 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcFeb 02 '24Sale49.602,125105,40435,825Feb 02 07:54 PM
BENNETT C FRANKEVP, Chief Scientific OfficerFeb 02 '24Sale49.521,85391,75279,079Feb 02 07:54 PM
Monia Brett PChief Executive OfficerJan 25 '24Sale51.752,285118,249151,851Jan 29 05:34 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 25 '24Sale51.756,450333,78846,802Jan 29 05:34 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 16 '24Option Exercise0.0015,062039,374Jan 18 06:07 PM
Cadoret-Manier OnaizaEVP, Chf GL Pdt Str & Oper OfcJan 17 '24Sale50.425,564280,52033,810Jan 18 06:07 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 16 '24Option Exercise0.0020,641060,996Jan 18 05:59 PM
O'NEIL PATRICK R.EVP CLO & General CounselJan 17 '24Sale50.427,744390,42953,252Jan 18 05:59 PM
Birchler BrianEVP, Corp and Development OpsJan 16 '24Option Exercise0.0012,080049,079Jan 18 05:55 PM
Birchler BrianEVP, Corp and Development OpsJan 17 '24Sale50.424,497226,72544,582Jan 18 05:55 PM
Swayze EricEVP ResearchJan 16 '24Option Exercise0.0021094Jan 18 05:49 PM
Swayze EricEVP ResearchJan 16 '24Option Exercise0.0017,069049,585Jan 18 05:49 PM
Swayze EricEVP ResearchJan 17 '24Sale50.426,296317,42543,289Jan 18 05:49 PM
Swayze EricEVP ResearchJan 17 '24Sale50.42945485Jan 18 05:49 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 16 '24Option Exercise0.0015,162053,332Jan 18 05:48 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 17 '24Sale50.425,482276,38647,850Jan 18 05:48 PM
Monia Brett PChief Executive OfficerJan 16 '24Option Exercise0.0068,0840186,195Jan 18 05:48 PM
Monia Brett PChief Executive OfficerJan 17 '24Sale50.4232,0591,616,319154,136Jan 18 05:48 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 16 '24Option Exercise0.0022,487099,573Jan 18 05:48 PM
HOUGEN ELIZABETH LEVP, Finance & CFOJan 17 '24Sale50.428,683437,77190,890Jan 18 05:48 PM
Geary Richard SEVP, Chief Development OfficerJan 16 '24Option Exercise0.0019,852092,813Jan 18 05:47 PM
Geary Richard SEVP, Chief Development OfficerJan 17 '24Sale50.427,338369,96085,475Jan 18 05:47 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 16 '24Option Exercise0.0018,314084,068Jan 18 05:44 PM
BENNETT C FRANKEVP, Chief Scientific OfficerJan 17 '24Sale50.426,745340,06377,323Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 16 '24Option Exercise0.001,35302,204Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 16 '24Option Exercise0.003,688014,259Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 17 '24Sale50.421,46073,60912,799Jan 18 05:44 PM
Baroldi JosephEVP, Chief Business OfficerJan 17 '24Sale50.4256428,4351,640Jan 18 05:44 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12 '24Option Exercise32.608,000260,80046,170Jan 17 08:51 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrJan 12 '24Sale53.508,000427,99938,170Jan 17 08:51 PM
Swayze EricEVP ResearchDec 28 '23Option Exercise47.3427,1001,282,91459,616Jan 02 05:54 PM
Swayze EricEVP ResearchDec 28 '23Sale50.1927,1001,360,08132,516Jan 02 05:54 PM
HOUGEN ELIZABETH LEVP, Finance & CFODec 28 '23Option Exercise47.3445,2252,140,952120,884Jan 02 05:54 PM
Birchler BrianEVP, Corp and Development OpsDec 28 '23Option Exercise47.3411,500544,41048,028Jan 02 05:54 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26 '23Option Exercise47.3420,825985,85661,180Dec 28 07:18 PM
O'NEIL PATRICK R.EVP CLO & General CounselDec 26 '23Sale51.4620,8251,071,71740,355Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 27 '23Option Exercise47.3450,0002,367,000132,588Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 28 '23Option Exercise47.3442,5252,013,134125,113Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 26 '23Option Exercise47.3425,1131,188,849107,701Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 27 '23Sale50.2350,0002,511,51582,588Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 28 '23Sale50.1942,5252,134,22382,588Dec 28 07:18 PM
PARSHALL B LYNNEDirectorDec 26 '23Sale51.4625,1131,292,39082,588Dec 28 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26 '23Option Exercise47.3425,0001,183,50061,052Dec 28 07:18 PM
Schneider EugeneEVP, Chf Clinical Develop OfcrDec 26 '23Sale51.4625,0001,286,57536,052Dec 28 07:18 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21 '23Option Exercise47.3416,113762,78981,867Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20 '23Option Exercise47.346,500307,71072,254Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 21 '23Sale49.2916,113794,21165,754Dec 22 07:11 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 20 '23Sale49.646,500322,64365,754Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20 '23Option Exercise47.346,500307,71079,461Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21 '23Option Exercise47.344,112194,66277,073Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 20 '23Sale49.646,500322,64372,961Dec 22 07:11 PM
Geary Richard SEVP, Chief Development OfficerDec 21 '23Sale49.294,112202,68172,961Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 21 '23Option Exercise47.3417,500828,450135,611Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 20 '23Option Exercise47.346,500307,710124,611Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 21 '23Sale49.2917,500862,577118,111Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 20 '23Sale49.646,500322,643118,111Dec 22 07:11 PM
Monia Brett PChief Executive OfficerDec 14 '23Option Exercise47.3424,0001,136,160132,971Dec 18 04:56 PM
Monia Brett PChief Executive OfficerDec 14 '23Sale49.5824,0001,190,019118,111Dec 18 04:56 PM
Geary Richard SEVP, Chief Development OfficerDec 14 '23Option Exercise47.3410,613502,41979,532Dec 18 04:55 PM
Geary Richard SEVP, Chief Development OfficerDec 14 '23Sale49.5810,613526,23672,961Dec 18 04:55 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14 '23Option Exercise47.3422,6121,070,45279,756Dec 18 04:55 PM
BENNETT C FRANKEVP, Chief Scientific OfficerDec 14 '23Sale49.5822,6121,121,19565,754Dec 18 04:55 PM
KLEIN JOSEPH IIIDirectorNov 15 '23Sale50.002,000100,00016,346Nov 17 04:58 PM
Swayze EricEVP ResearchOct 16 '23Option Exercise0.001250125Oct 18 06:40 PM
Swayze EricEVP ResearchOct 17 '23Sale47.95522,49373Oct 18 06:40 PM
Monia Brett PChief Executive OfficerOct 12 '23Sale46.003,770173,420118,111Oct 16 04:35 PM